The regional distribution of iron, copper, zinc, magnesium, and calcium 
Introduction
Transition metals such as iron, copper, and zinc are known to play a cmcial role in various physiological functions in mammalian brains, for example, in prosthetic groups of metalloenzymes and in the control of gene expression (O'Halloran 1993) . Transition metals have been linked primarily to neurological disorders such as Wilson's disease, Hallervorden-Spatz syndrome, Parkinson's disease and Alzheimer's disease (e.g., Riederer et al 1989; Constantin; -dis 1991; Good et al 1992) . C,~,sidvfing the c~tical rote of transition metals in enzyme and receptor function, however, excess or deficiency of these elements might also be related to the pathophysiology of schizophrenia.
Zinc is unevenly distributed within the brain with particularly high concentrations in the hippocampal mossy fiber system, where it acts as a neuromodulator (Xie and Smart 1991) . Interactions with inhibitory (Smart and Constanti 1990) and excitatory amino acid neurotransmission (Yet et a11990) are well known. Although low to moderate concentrations of zinc attenuate N-methyl-o-aspartate (NMDA)-mediated and enhance quisqualate-mediated neurotoxicity (Koh and Choi 1988) , high concentrations of zinc are neurotoxic (Yokoyama et al 1986) . Zinc deficiency has been hypothesized to be an important factor in the pathogenesis of schizophrenia (Kimura and Kumura 1965; Pfeiffer and lliev 1972; Andrews 1990 ). Enhanced concentrations of zinc could be linked to the pathophysiology of schizophrenia, too. The glutamate hypothesis of schizophrenia proposes that a deficiency in glutamatergic neurotransmission and a resulting disturbance in balance between glutamatergic and dopaminergic systems within the ba~l ganglia may play a key role in the pathophysiology of schizophrenia (Kim et al 1980; Komhuher et al 1989a) . Zinc inhibits transmission at the NMDA receptor (Yeh et al 1990) . Enhanced activity of zinc at the NMDA receptor might thus be involved in the pathophysiology of schizophrenia. Results of direct measurements of zinc in human postmortem brain tissue are inconsistent. Kimura and Kumura (1965) found a 50% decrease in the zinc concentration in the hippocampus of schizophrenic patients and McLardy (1973) found a 30% reduction in zinc content in the brains of patients with early onset schizophrenia. Greiner et al (1975) found no differences in zinc content in several brain regions, however, the hippocampus was not investigated by these authors. No consistent differences in the content of zinc were found in cerebrospinal fluid (Potkin et al 1982) or plasma (Gillin et al 1982) of schizophrenic patients.
There are several findings linking schizophrenia to disturbed iron metabolism. Iron exerts a profound influence on dopaminergic neurotransmission and behavior in laboratory animals (Yehuda and Youdim 1988) . Low serum iron levels were reported in patients suffering from neurolepticinduced side effects, that is, akathisia (Brown et al 1987) and neuroleptic malignant syndrome (Rosebush and Mazurek 1991) . Some investigators had the impression of increased iron staining in postmortem brain sections (Josephy 1930; Stevens 1982) . Recently, iron was quantified in postmortem brains from schizophrenic patients using optical density measurements of coronal sections stained with the Pearl's technique (Casanova et ai 1992) . In that study stainlag intensity of iron was significantly increased in the candate nucleus, which was attributed to neuroleptic therapy.
The main support for a copper hypothesis of schizophrenia comes from repeated findings of elevated copper and coeruloplasmin concentrations in the serum of schizophrenic patients (Bowman and Lewis 1982) . Several copper-dependent enzymes are involved in catecholamine metabolism. More recent investigations, however, found unchanged copper levels in plasma and urine (Gillin et al 1982) , cerebrospinal fluid (Shore et al i983) , and brain (Greiner et al 1975) of schizophrenic patients.
Besides the above-mentioned transition metals, changes in calcium and magnesium levels have also been linked to the pathophysiology of schizophrenia (Alexander and Jackson 1981 ) . Direct measurements of these metals in postmortem human brain tissue have revealed no significant abnormalities in schizophrenia (Greiner et a11975), however. The aim of the present study is to assess the content of iron, copper, zinc, magnesium, and calcium in several brain regions of schizophrenic patients and controls.
Materials and Methods
Postmortem handling of the autopsy materi~ was similar in all cases. Brains were obtained at autopsy from ! 2 subjects (!0 women, 2 men) with no history of neurological or psychiatric disorders. Control subjects had a mean age of 75.3 +-7.1 years (_ SD, range 41-91 years). This group was compared to ! I schizophrenic patients (6 women, 5 men) diagnosed according to both Feighner et ai (1972) and to the International Classification of Diseases (1CD-9). These patients had a mean age of 69.6 +_ 8.2 years (range 57-80 years). The diagnostic subgroups according to the ICD-9 were schizophrenia simplex (ICD 295.0, n = I), hebephrenic subtype (ICD 295. !, n = I), paranoid subtype (ICD 295.3, n = i), chronic schizophrenia (ICD 295.6, n = 7), and schizoaffective psychosis (ICD 295.7, n = !). ~;ecause there may be racial difference in the metabolism of certain metals (Potkin et al 1982) , only brain specimens from Caucasian patients were investigated. Histopathological examination was performed on all brains to exclude other abnormalities such as rumor, infarction, anoxia, brain atrophy, and Alzheimer's disease. Postmortem delay time (i.e., time between death and freezing) was less than 24 hr in all cases. A detailed examination of case notes was made to establish whether the patients had received neuroleptic medication during the period leading up to death. Three patients had been drug-free for at least 1 year and 7 patients were drug free for at least 3 months. Putamen samples from all the schizophrenic patients and three of the controls had previously been analyzed for [3H]spiperone binding (Kornhuber et al 1989b) . Brain tissue was taken from the caudate nucleus, hippocampus, amygdala, cortex, corpus mamillare, ~/rus cinguli, and hypothalamus from both hemispheres. It was not possible to collect samples of all seven regions from every brain (Table 1) The tissue was quickly frozen and stored at -70°C until analysis Iron, copper, zinc, magnesium, and calcium were determined by an atomic absorption procedure (Stevens 1970) . Thawed tissue was freeze-dried at -60°C and 10-: T for 24 hr. Thereafter, the dry tissue was weighed and dissolved in acid-washed vials with I ml of 65% nitric acid p.a. at ! 10°C. The evaporated dry residue was taken up into 5 ml of the diluent. Atomic absorption spectroscopy was performed using a Zeiss PMQ II photometer.
Results are expressed as micrograms per gram dry weight. Mean values are given + SD. Nonparametric statistics (Mann-Whitney U-test, Fisher's exact probability test, Spearman's rank correlation, Kruskal-Wallis one-way ANOVA) were used throughout using the two-tailed approach. P-values higher than 0.05 were regarded as not 19q4"~b:31-34 Theeefome. the case data ate lisled for each region ~parately. Mean values me given -+ SD.
No differences in the COmlem of an), of the five metals between controls and ~hizophrenic patients were observed (Mann-Whitney U-le~ p > 0.05). significant. Because of the explorative nature of the study, no et-conectious were applied.
Results
Data on case histories and results are given in Table 1 . Age and gender were not significantly different between controis and schizophrenic patients. When the control and ©rhiT,-u~hm~nio or~**n~ worp enmnared nn differences in the content of any ofth~ five metals investigated were observed (Table 1) . Looking at the total group (controls and schizophrenics combined), magnesium was distributed homogeneously in the seven brain regions investigated (Table 2) , but there were significant regional differences for the other metals. For iron and copper, we found higher concentrations in the caudate nucleus than ;.n ~he hl.ppoca.mp~Js and amygdala. Zinc concentrations were highest in the hippocampus, with decreasing values in the amygdala and candate nucleus ( Table !) .
The effect of gender was investigated for each brain region using the total group (controls and schizophrenics) and the schizophrenic subgroup, respectively. The low number of men in the controls did riot allow a meaningful comparison in this group. Except for zinc, none of investigated metals were significantly different in men compared to women, either in the total group or in schizophrenics (data not shown). In the total group there was a gender difference in zinc content only in the hippocamp~ (76.2 + 6.2 in men versus 88.6 + 10.6 in women, itg/g dry weight. p < 0.01). In schizophrenic patients, there was a gender difference in the caudate nucleus (47.6 + 12.3 in men versus 65.9 _+ 13.1 in women, ixg/gdryweight,p < 0.05) and in the hippocampus (77.1 -+ 6.8 in men versus 88.3 ---8.8 in women, ixg/g dry weight, p < 0.05). There was no correlation between the neumleptic-free period before death and the content of any of the metals investigated, except ~or a positive correlation between copper and the neurolepticfree period in the hippocampus (r = 0.83, p < 0.02). One schizophrenic female aged 77 years had suffered from tardive dyskinesia before death. In this patient, the contents of all metals investigated were within the mean _ 2 SD range of schizop,hrenic patients widumt tardive dyskinesi~
Discussion
The metal concentrations and the regional distributions found in this study we, re generally in accordance with previous investigations on human brain material (Harrison et al 1968; Vi~lkl and Ule i 972; Ule et ai ! 974; Riederer et al 1989) . In none of the brain regions investigated significant differences were observed between schizophrenics and controls. Because a number of the patients will have received long-term anfipsychotic drug treatment, it is conceivable that this may have had an effect on the content of the metals investigated. Theoretically, a preexisting difference in the metal content could have been masked by neuroleptic drugs. Except for the copper content in the hippocampus, however, the neuroleptic-free time before death had no impact on the metal concentrations. The functional signifi-BIOL PSYCHIATRY J. Komhuber et al 1994:36:31-34 cance of the positive correlation between copper level and neuroleptic-free time before death should not be over-interpreted because of the explorative nature of the study (no a-corrections were applied).
Taken together, the results of the present study show that
